Procedure Deep-Dive · November 21, 2026
Fabry Disease and Cosmetic Surgery: Angiokeratomas, Lasers, Heat Intolerance, Sweating, Kidney and Heart Disease, Nerve Pain, Enzyme Therapy, and Migalastat
The tiny dark red dots across the lower belly and hips look like a cosmetic nuisance, the kind of thing a laser clears in an afternoon. In some adults they are angiokeratomas, the skin sign of Fabry disease, an inherited enzyme deficiency that also damages the kidneys, the heart, the nerves, and the sweat glands. Here is what the dots mean, how to treat them, and why a patient who cannot sweat needs a different plan in the operating room.
By The Editorial Desk
18 min read

He is 34 and wants the dots gone. They started in his late teens as a few pinpoint red spots below his navel and have since spread in a loose band across his lower abdomen, his hips, the tops of his thighs, and his buttocks. They are dark red to almost purple, slightly rough, and they bleed when he catches one with a razor. A friend told him they were cherry angiomas. He books a consultation for laser removal, and while he is there he asks about a tummy tuck, because a decade of on-and-off stomach trouble has left him self-conscious about his midsection.
The history is where the case changes. Since childhood he has had burning pain in his hands and feet that flares in summer, during fevers, and after exercise. He says he "basically does not sweat" and has to stop running on hot days because he overheats. His maternal uncle started dialysis at 41. His mother, who has always been "the healthy one," had a pacemaker placed at 56 and was told her heart muscle was thick.
That combination points to Fabry disease. The dots are angiokeratomas, not cherry angiomas. The burning hands and feet are a small fiber neuropathy. The missing sweat is a direct effect of the disease on sweat glands. And the family pattern, an uncle with kidney failure and a mother with heart disease, is how an X-linked condition travels through a family. A laser can treat the dots. Before that, and long before a tummy tuck, he needs a diagnosis, because Fabry disease is treatable, and the organs it threatens are not the ones he came in to discuss.
What Fabry disease is, and why diagnosis takes so long
The short answer: Fabry disease is an inherited deficiency of an enzyme called alpha-galactosidase A, which lets a fatty substance build up in blood vessel walls, kidneys, heart, nerves, and sweat glands, and because its early signs look like ordinary complaints, adults commonly go more than a decade between first symptoms and diagnosis.
The GLA gene, which sits on the X chromosome, makes the enzyme alpha-galactosidase A. Its job inside cells is to break down a fatty molecule called globotriaosylceramide, usually shortened to Gb3, in the cell's recycling compartment, the lysosome. When the enzyme is missing or weak, Gb3 and a related molecule called lyso-Gb3 accumulate slowly over years in the cells lining blood vessels, in the kidney's filters, in heart muscle, in the small nerves that carry pain and temperature, and in sweat glands. That is why Fabry disease belongs to the family of lysosomal storage disorders, alongside the Gaucher disease we covered earlier.
Medical references describe two broad patterns:
- Classic Fabry disease: usually in males with little or no enzyme activity. Symptoms begin in childhood or adolescence with burning pain in the hands and feet, reduced sweating, heat and exercise intolerance, abdominal pain and diarrhea, and angiokeratomas. Without treatment, protein in the urine and declining kidney function follow in early adulthood, then thickened heart muscle, rhythm problems, and strokes, often in the thirties to fifties.
- Later-onset (nonclassic) Fabry disease: usually caused by gene variants that leave some enzyme activity. These patients may have few or no childhood symptoms and present in middle age with heart disease that looks like hypertrophic cardiomyopathy, or with kidney disease or a stroke of unclear cause. Skin signs are often absent.
Classic Fabry disease has traditionally been estimated at roughly 1 in 40,000 males, but newborn screening programs in several countries have found disease-associated GLA variants far more often, on the order of one in a few thousand male births, most of them later-onset forms. The condition is almost certainly underdiagnosed.
Women are patients, not just carriers. Because the gene is on the X chromosome, an affected father passes it to every daughter and no sons, and an affected mother has a 50 percent chance of passing it to each child. Women were long described as carriers, but because each cell in a woman's body randomly silences one of her two X chromosomes, women with a GLA variant range from symptom-less to severely affected. Many have pain, heart involvement, kidney disease, or strokes, typically later and more variably than men. A woman's enzyme level can look normal on a blood test even when she has the disease, which is why genetic testing, not enzyme activity alone, is needed to diagnose women.
Diagnosis is straightforward once someone suspects it. In males, low alpha-galactosidase A activity on a blood test points to the answer, and GLA gene sequencing confirms it. In females, gene testing is required. A blood level of lyso-Gb3 helps gauge disease burden. The hard part is the suspicion. Burning feet get labeled growing pains, stomach trouble gets labeled irritable bowel syndrome, and the skin dots get labeled cherry angiomas. Studies of Fabry registries consistently describe diagnostic delays of a decade or more. A cosmetic consultation about red dots on the lower body can be the moment the pattern finally gets named.
Angiokeratomas: the dark red dots that are not cherry angiomas
The short answer: Fabry angiokeratomas are small, dark red to blue-black, slightly rough bumps made of dilated capillaries under thickened skin, classically clustered between the navel and the knees, and they differ from ordinary cherry angiomas in their color, texture, location, and age of onset.
Dermatologists call the classic Fabry pattern angiokeratoma corporis diffusum, and they describe it with a memorable phrase: the "bathing trunk" distribution. The lesions concentrate on the lower abdomen, around the navel, in the groin, on the buttocks, on the hips, and on the upper thighs, roughly the area a swimsuit would cover. They can also appear on the lips, inside the mouth, and on the scrotum or vulva. Large registry studies have found angiokeratomas in a majority of men with classic Fabry disease and in roughly a third of women, and they tend to appear in adolescence and increase in number with age. Some patients have hundreds. Some have five.
How they differ from the lookalikes:
- Cherry angiomas: bright red, smooth, dome-shaped, scattered mostly on the trunk and arms, appearing from the thirties onward and becoming nearly universal with age. They are harmless and have nothing to do with Fabry disease. Angiokeratomas tend to be darker, flatter or slightly warty on the surface, and they start earlier.
- Angiokeratomas of Fordyce: dark red to purple papules confined to the scrotum or vulva, very common in older adults, and usually unrelated to any systemic disease. Isolated genital lesions in a middle-aged person rarely mean Fabry. Lesions spreading across the trunk in a young adult deserve more thought.
- Solitary angiokeratomas: a single dark papule, often on a leg, sometimes mistaken for melanoma because it can look nearly black. A dermatologist can usually tell the difference with a dermatoscope, and a biopsy settles any doubt.
- Petechiae and spider veins: pinpoint bleeding spots and fine thread veins, which flatten or fade differently under pressure.
A diffuse angiokeratoma pattern is not unique to Fabry disease; a few even rarer lysosomal disorders, such as fucosidosis, can produce it, and some people have widespread angiokeratomas with no detectable disease at all. That is why the skin finding is a reason to test, not a diagnosis in itself. The clue that should change the conversation is the combination: angiokeratomas in a bathing trunk pattern plus any of burning hands and feet, poor sweating, heat intolerance, unexplained kidney or heart disease, or a family history of early dialysis, pacemakers, or strokes.
Other skin and surface findings can travel with Fabry disease. Fine red telangiectasias may appear on the face, trunk, or lips, similar in appearance to the broken capillaries many patients treat cosmetically. Some adults develop swelling of the legs from lymphatic involvement. An eye doctor may spot whorl-shaped deposits on the cornea called cornea verticillata, which rarely affect vision but are a strong clue (the same pattern can be caused by the heart drug amiodarone). Some research has described subtle facial features in men with classic disease, such as fuller lips and a more prominent brow, but these are not reliable enough to diagnose anyone, and no patient should be told they "look like" they have a genetic condition.
"An angiokeratoma is a three-millimeter clue to a disease that lives in the kidneys, the heart, and the brain. Lasering the clue without asking why it is there treats the evidence and closes the case too early."
Lasers, excision, and planning cosmetic procedures around the skin
The short answer: angiokeratomas respond to vascular lasers, intense pulsed light, electrosurgery, and excision, but enzyme therapy does not reliably clear them and new lesions keep forming, so treatment is maintenance, and any body procedure in the bathing trunk zone has to account for them.
Treatment is reasonable and often worth it. The lesions can bleed when shaved, scratched, or rubbed by waistbands and compression garments, and many patients find them embarrassing in intimate settings. The options:
- Vascular lasers: the pulsed dye laser and the 532 nm KTP laser target the red blood in the dilated capillaries and work well on smaller, redder lesions, the same devices used for facial redness and port-wine stains. Darker, deeper lesions may need a long-pulsed Nd:YAG laser, which penetrates further but carries more risk of scarring if settings are aggressive.
- Intense pulsed light: some case series describe good results on widespread lesions, especially when many small ones need treatment at once.
- Electrosurgery, shave, and excision: practical for a few large or raised lesions, and similar to how surgeons remove other benign skin growths. The keratotic surface may need to be addressed along with the vessels.
- Multiple sessions: dense fields usually need several treatments spaced weeks apart, and treated skin can stay darker or lighter for months, particularly in medium and deeper skin tones, a risk discussed in our guide to ablative and non-ablative laser resurfacing.
Patients should know that enzyme replacement therapy and migalastat, the drugs that treat the disease itself, have not been shown to reliably shrink existing angiokeratomas, and new ones can keep appearing. The honest framing is the same one we used for the angiofibromas of tuberous sclerosis: a laser removes what is there, and touch-ups are part of the plan.
The tummy tuck problem. The lower abdominal incision of an abdominoplasty runs straight through the classic angiokeratoma zone. That is not a reason to refuse surgery, and in one sense it helps: the skin that is removed takes many lesions with it. But the surgeon should map the lesions before the operation, avoid placing the incision line through a dense cluster when there is a choice, expect more bleeding from lesions near the cut edge, and warn the patient that lesions on the remaining skin and around the repositioned navel will stay. The same thinking applies to lower body lifts, thigh lifts, and buttock procedures. Our piece on old abdominal scars and tummy tucks explains why surgeons want to know everything about the skin they are about to move.
Liposuction and compression. Cannula entry points should not be placed through angiokeratomas, which bleed easily and may heal poorly as a portal. Compression garments rub the hips and lower abdomen for weeks, which is where lesions concentrate, so a patient with many lesions should expect some to bleed and crust. Soft liners or garments with seams placed away from clusters help. The general evidence on compression garments applies, with one added concern covered below: heat.
Laser hair removal in the bikini area. Hair removal lasers target pigment, but vascular lesions absorb laser energy too. Passing a diode or alexandrite laser over a field of angiokeratomas can cause pain, blistering, and bleeding. A provider doing laser hair removal in the groin, buttocks, or thighs should know the diagnosis and either shield the lesions or treat them deliberately as a separate step.
Leg swelling. Some adults with Fabry disease develop swelling of the legs from lymphatic dysfunction, and others develop swelling from kidney or heart disease. Before anyone offers liposuction for "heavy legs," the cause of the swelling needs to be known, for the reasons laid out in our guides to lymphedema and lipedema. Fluid from a failing kidney or heart is not a contouring problem.
Injectables and facial work. Fabry disease does not rule out neurotoxin, fillers, or facial surgery. Lip angiokeratomas should be avoided with the needle, and patients who take blood thinners for heart rhythm problems or after a stroke will bruise more. The kidney and heart questions below matter for any procedure under general anesthesia, wherever the incision is.
Heat, sweating, and nerve pain: the operating room problem nobody mentions
The short answer: many people with Fabry disease sweat very little and cannot shed heat normally, and their nerve pain flares with fever, heat, exertion, and stress, so warming strategies, heat-based devices, compression garments, and postoperative pain plans all need adjusting.
Hypohidrosis is common and underappreciated. Reduced sweating, and sometimes almost no sweating, affects a large share of men with classic Fabry disease and a smaller share of women. Gb3 deposits in the sweat glands and damage to the small nerves that control them both contribute. Patients describe flushing, dizziness, and exhaustion in hot weather, an inability to finish a workout, and a habit of seeking out air conditioning. This is the opposite of the problem treated in our article on Botox for excessive sweating, and it carries real risk in surgical settings.
In the operating room, most of the effort goes into preventing patients from getting cold, because hypothermia raises bleeding and infection risk, as described in our piece on shivering and hypothermia after surgery. Forced-air warming blankets, warmed fluids, and warm rooms are standard. In a patient who cannot sweat, the anesthesia team should monitor core temperature continuously and be ready to turn warming down, not just up. Overheating can also trigger a pain crisis on waking.
Heat-based devices deserve a second look. Radiofrequency skin tightening, laser-assisted and ultrasonic liposuction, and helium plasma devices deliver heat under the skin by design. Our explainer on skin tightening with liposuction describes how these devices work. They are not forbidden in Fabry disease, but treating a large area in a patient with impaired heat regulation, under general anesthesia, during a long case, adds up. Some surgeons will choose a more conservative plan or treat smaller areas per session.
Compression in summer. A full-body compression garment worn around the clock for weeks traps heat. For most patients that is a nuisance. For a patient who cannot sweat, it can mean overheating, flushing, and pain flares, especially in a warm climate or a home without air conditioning. A practical plan includes timing elective body surgery for cooler months when possible, cooling strategies at home, breathable garments, and clear instructions about when it is acceptable to remove the garment briefly to cool down.
Nerve pain and pain crises. The small fiber neuropathy of Fabry disease causes chronic burning, tingling, or electric pain in the hands and feet, and episodic "Fabry crises" of severe pain that can last hours to days. Crises are classically triggered by fever, heat, exercise, emotional stress, and rapid temperature changes, all of which cluster around surgery. What helps:
- Keep neuropathic medications going. Many patients take carbamazepine, oxcarbazepine, gabapentin, pregabalin, or certain antidepressants for nerve pain. These should be continued through surgery unless the prescribing physician says otherwise. Carbamazepine speeds up the breakdown of some anesthetic and pain medications, the same interaction issue discussed in our guide to trigeminal neuralgia.
- Expect opioids to underperform. Neuropathic pain responds poorly to opioids, and Fabry patients may need a multimodal plan built around their existing nerve pain regimen rather than escalating narcotic doses. The principles in our article on chronic pain after cosmetic surgery apply with extra force.
- Treat fever early. A postoperative fever is a crisis trigger as well as a possible sign of infection. Acetaminophen is usually preferred; anti-inflammatory painkillers may be off the table because of the kidneys.
- Document nerve symptoms before nerve blocks. Regional anesthesia is not contraindicated, but a patient with an existing neuropathy should have their baseline symptoms recorded so that numbness or tingling afterward is not wrongly blamed on the block.
The gut and the circulation. Many Fabry patients have abdominal pain, cramping, diarrhea, early fullness, and bloating from involvement of the nerves and vessels of the intestine. That history matters in two ways. A protruding, bloated abdomen may not be the fat or loose skin a tummy tuck fixes, and a surgeon should hear about the stomach symptoms before promising a flat result. And some patients have autonomic problems, including lightheadedness when standing, that overlap with the issues in our piece on POTS and dysautonomia.
Kidneys, heart, stroke, and enzyme therapy before elective surgery
The short answer: the threats that define Fabry disease are kidney failure, heart muscle thickening with rhythm problems, and early strokes, and an adult planning elective surgery needs current kidney and cardiac testing, a coordinated plan for enzyme replacement or migalastat, and an anesthesia team that knows the history.
The kidneys. Gb3 builds up in the kidney's filters early, and protein in the urine is often the first measurable sign. Untreated classic disease historically led to kidney failure in the thirties to fifties, and Fabry disease remains a recognized cause of dialysis and transplant. For surgery, the practical points match those in our guide to chronic kidney disease before cosmetic surgery: know your kidney function and urine protein level, avoid anti-inflammatory painkillers unless your nephrologist approves them, adjust doses of medications cleared by the kidneys, protect any dialysis access arm, and if you have had a kidney transplant, plan around your antirejection medications. Many Fabry patients take an ACE inhibitor or an ARB to reduce protein loss, and the anesthesia team will decide whether to hold it on the morning of surgery.
The heart. Heart involvement is now the leading cause of death in Fabry disease. Gb3 thickens the left ventricle, a pattern that can be mistaken for hypertrophic cardiomyopathy, and scarring of the heart muscle leads to rhythm problems: slow heart rates, conduction block, atrial fibrillation, and dangerous ventricular rhythms. Some patients need a pacemaker or an implanted defibrillator. Later-onset variants may cause heart disease with almost nothing else. Before a major elective operation, an ECG is a minimum, and many patients will need an echocardiogram or a recent cardiac MRI, which in Fabry disease shows a characteristic pattern that helps track progression. Patients with a device need the coordination described in our piece on pacemakers and defibrillators, and those with reduced heart function face the fluid limits discussed in our article on heart failure and cosmetic surgery, which directly constrain large-volume liposuction.
Strokes and blood thinners. Fabry disease raises the risk of transient ischemic attacks and strokes at young ages, sometimes before any other diagnosis is made, and MRI often shows small vessel changes in the brain's white matter. Patients with a history of stroke or with atrial fibrillation often take aspirin, clopidogrel, or an anticoagulant. Those drugs should not be stopped for a cosmetic procedure without the prescribing physician's agreement, and the bridging decisions follow the logic of our guide to blood thinners before cosmetic surgery. A recent stroke is a reason to postpone elective surgery, typically for months, not weeks.
Ears and lungs. Hearing loss and ringing in the ears are common in adults with Fabry disease, and patients with hearing aids should read our piece on hearing aids and facelift incisions before facial surgery. Some patients have mild airflow obstruction in the lungs, which is worth mentioning to the anesthesiologist, particularly for smokers.
Enzyme replacement therapy. The FDA approved agalsidase beta (Fabrazyme) in 2003 and pegunigalsidase alfa (Elfabrio) in 2023. Both are given by intravenous infusion, usually every two weeks, at an infusion center or at home. A third product, agalsidase alfa, is used in many other countries but is not approved in the United States. Treatment can stabilize kidney function and slow heart involvement, particularly when started early, and it often reduces pain and improves sweating somewhat. For surgical planning:
- Keep the schedule. Missing one infusion is not an emergency, but surgery is not a reason to drift off schedule. Most teams time the infusion a few days before or after the operation rather than on the same day.
- Infusion reactions and antibodies. Some patients, especially men with classic disease, develop antibodies to the enzyme and have infusion reactions that require premedication with antihistamines or steroids. A patient who receives steroids before each infusion should tell the surgeon, because steroids affect wound healing and blood sugar.
- Ports. Some patients receive infusions through an implanted chest port. A port sits close to where breast and chest procedures happen, so a surgeon planning a breast augmentation, reduction, or lift should know exactly where it is. Our guide to port scars and cosmetic surgery covers how surgeons work around them.
Migalastat. Migalastat (Galafold), approved by the FDA in 2018, is an oral pill for adults whose specific GLA variant is "amenable," meaning the faulty enzyme can be stabilized by the drug so it works better. It is taken every other day, and the label instructs patients to avoid food and caffeine for two hours before and two hours after each dose. That rule interacts with surgery in a simple but easily overlooked way: fasting, nausea, and irregular meals after anesthesia can scramble the timing. Patients should work out with their Fabry specialist whether the dose falls on the day of surgery and how to keep the every-other-day rhythm through recovery. Several other treatments, including substrate reduction pills and gene therapies, are in clinical trials, and patients enrolled in a trial should tell the trial team before any elective procedure, because many protocols restrict surgery and new medications.
Where and how. A few angiokeratomas treated with a vascular laser in a dermatology office need no special planning beyond the diagnosis. General anesthesia for a tummy tuck, liposuction, or breast surgery in a patient with Fabry disease is different: it belongs in an accredited facility with an anesthesiologist who has reviewed the kidney and heart workup, the ability to monitor core temperature and heart rhythm, and a clear transfer plan. Our guides to anesthesia choice and the operative plan, outpatient facility accreditation, and hospital privileges explain what to ask. Patients with significant heart or kidney disease may be safest having elective surgery at a hospital affiliated with their Fabry center.
The honest summary
Fabry disease is uncommon, but its skin sign sits exactly where body contouring happens, which means cosmetic providers meet undiagnosed patients more often than anyone tracks. Dark red, slightly rough dots spreading between the navel and the knees in a young adult, especially alongside burning hands and feet, poor sweating, heat intolerance, unexplained stomach trouble, or a family history of early dialysis, pacemakers, or strokes, should lead to testing before treatment. In men, an enzyme blood test and gene sequencing settle it. In women, gene testing is required, because a normal enzyme level does not rule the disease out.
For the skin itself, the options are good. Vascular lasers, intense pulsed light, electrosurgery, and excision can clear angiokeratomas, with the honest caveat that new lesions keep forming and the drugs that treat Fabry disease do not reliably erase the ones already there. Body procedures in the bathing trunk zone, including tummy tucks, liposuction, lifts, and laser hair removal, should be planned around the lesions rather than discovered on the table.
For anything bigger than an office laser, the skin is the least important organ in the room. A patient who cannot sweat needs temperature monitoring and a different approach to warming, heat-based devices, and compression. Nerve pain medications must continue, and fever and stress are pain triggers. Kidney function shapes which drugs are safe, the heart may hide thickened muscle and rhythm problems, a history of stroke brings blood thinners into the plan, and enzyme infusions or migalastat dosing need to be coordinated with the surgery date. None of that rules out cosmetic surgery for a stable adult with well-managed Fabry disease. It does fix the order: diagnosis, current kidney and heart testing, a plan from the Fabry team, a surgeon and anesthesiologist who understand the condition, and only then the procedure. If a provider wants to laser the dots or schedule the tummy tuck without asking why you never sweat, get a second consultation first.